South African pharmaceutical company Aspen Pharmacare announced on Monday, December 29th, the sale of its main Asia-Pacific operations (excluding China) to Australian private equity fund BGH Capital for 2.37 billion Australian dollars, approximately 1.59 billion US dollars. This transaction, which includes markets in Australia, New Zealand, Hong Kong, Taiwan, Malaysia, and the Philippines, is part…...
Trending
- Africa50 mobilizes $20 million from BII and signs multiple infrastructure agreements in Tanzania
- Mauritania: Revised Budget for 2026 at 140.3 Billion MRU, Equivalent to 3.5 Billion Dollars
- Guinea-FMI: preliminary agreement on a $425 million program
- Botswana: Continental Reinsurance launches a public offer of 156 million USD before its IPO
- Cameroon: Paul Biya breaks his record of absence, 64 days out of the country
- Senegal: FONSTAB and BNDE inaugurate the first Senegalese industrial unit for hatching egg production
- Senegal: Widening of the trade deficit in June 2026
- Stanbic Holdings expects revenue growth in the second half thanks to credit recovery
South African Aspen Pharmacare sells key Asia-Pacific operations for $1.6 billion
By Félix NZALÉ
Félix NZALÉ
Félix Nzalé is a Senegalese journalist with a deep passion for cultural issues. He led the "CULTURE" section of SUD QUOTIDIEN (SUD Communication Group) for 10 years. Holder of dual Master’s degrees in Sociology and Philosophy, he also holds a management diploma from the Institut Supérieur de Management (ISM) in Dakar. He has contributed to the development of editorial concepts for several newspapers in Dakar.
Add A Comment
About us
Headed by Adama Wade and his team of 20 journalists, Kapital Afrik offers strategic and financial information to executives and managers. The aim of Kapital Afrik is to provide financial and political news, give priority to human entrepreneurial experiences, lend life to economic policies, give meaning to statistics….
Contact us: redaction@financialafrik.com